Our Mission

History

Missions & Values

Offices & Facilities




Our Mission

We are a company specializing in advanced rapid in vitro immunodiagnostic test systems and electrical bio-sensing system, particularly the blood glucose monitoring system for every day usage.
 

At TysonBio, we are taking a different approach to the diagnostic of diseases—one focused on developing, acquiring, and commercializing devices to detect and monitor the disease without compromising patient quality of life.

We target development and registration strategies in the United States, Europe, and the rest of the world to facilitate and to obtain regulatory approval in order to assist our partners on accelerating and meeting their health and medical device registration requirements in their perspective countries.

We plan to devote a substantial portion of our efforts to develop glucose monitoring system, and to advance its functions and features to make it more user friendly and meeting the exact needs of diabetics.

We have development capabilities to expand our portfolio of improved versions of currently marketed glucose monitoring system and immunodiagnostic test. In addition, we are actively researching novel medical monitoring devices to compliment our current portfolio within the domain of diabetes management.

Our goal is to build a leading, vertically integrated biomedical manufacturing company with a focused portfolio of proprietary diabetic monitoring system and in vitro immunodiagnostic testing system. With our in-house manufacturing facility and capability covering both the Electromedical and Biochemical devices and reagent, we are uniquely position to serve all of our value partners, and together, striving to provide a safer, more effective diagnostic devices that can make a meaningful difference to millions.
 


 

History
Founded in 1999, Tyson Bioresearch Inc. is an innovative medical diagnostic manufacturing company dedicated to providing products and services to accelerate the development and commercialization of diagnostics. The Company supplies its products and services worldwide to research organizations, biomedical and medical device distribution companies.

Milestone

Year

Events

01/2009


EZ Take Lancing Device receives Class I Ministry of Health issued Medical Device Certificate  (No.000620) ß this second line should be after the bullet point “Ÿ”, perpendicular to the first letter “E”
Received Taiwan Patent announcement on Integrated Blood Medical Diagnostic Device

08/2008

TysonBio Link Health Management System (EZ Smart, Diachex, and Diachex+ model series) receive FDA approval (510K# K081726)

07/2008

Perfect Mini Blood Glucose Monitoring System receives FDA approval (510K# K052818A006)

06/2008





Receive approval of initial public offering form Securities and Futures Bureau
EZ Plus Glucose Monitoring System receives Ministry of Health issued Medical Device Certificate (No.002586)
Diachex Basic, Diachex Superb, and Diachex Vigor Glucose Monitoring System receive FDA approval (510K# K072854)

04/2008







Received Taiwan Patent (M334703) on " Integrated Blood Medical Diagnostic Device "
T514, T513, T512 Glucose Monitoring System receives People's Republic of China SDA approval (No.2008_2400022)
Smartchex Control Glucose Monitoring System receives People's Republic of China SDA approval (No.2008_2400026)
Diachex+ Determine and Diachex+ Infinity Blood Glucose Monitoring System receives FDA approval (510K# K073492)

03/2008



Clarity Blood Glucose Monitoring System receives FDA approval (510K# K062829/A003)
EZ Scan Plus Blood Glucose Monitoring System receives FDA approval (510K# K072441)

02/2008




Obtained People's Republic of China patent on "Multi-functions Portable Diagnostic Device & Display Method" (No.381064)
T502 Glucose Monitoring System receives People's Republic of China SDA approval (No.2008_2400010)

11/2007


Merge and acquire Mihorng Technology Ltd

10/2007


Ultimate EZ Smart Plus Blood Glucose Monitoring System receives FDA approval (510K# K052818/A005)

08/2007



Diachex Blood Glucose Monitoring System receives Ministry of Health issued Medical Device Certificate (No.002460)
Smartchex Blood Glucose Monitoring System receives Ministry of Health issued Medical Device Certificate (No.002461)

06/2007




EZtake Lancing Device receives Ministry of Health issued Medical Device Certificate (No.001901)
EZ Smart 608 Blood Glucose Monitoring System receives FDA approval (510K# K062829A002)

04/2007


Received Taiwan Patent (I 279222) on "Multi-functions Portable Diagnostic Device & Display Method"

03/2007


Smartchex Blood Glucose Monitoring System receives FDA approval (510K# K052818A004)

01/2007

EZ Scan Blood Glucose Monitoring System receives Ministry of Health issued Medical Device Certificate (No.002309)

12/2006




HIV One Step Rapid Test & Glucose Monitoring System received Quality Product Silver Medal from Taiwan Biotechnology & Medical Committee.
Taiwan National Health Research Institute & regional Health Department receives a donation of 10,000 HIV One Step Rapid Tests for nation-wide HIV screening campaign

11/2006

Received Taiwan Patent (I 274876) on "Multi-detection Biosensor Strip"

10/2006

Diachex Blood Glucose Monitoring System receives FDA approval (510K# K062829)

09/2006

EZ Smart 608 Blood Glucose Monitoring System receives Ministry of Health issued Medical Device Certificate (No.002178)

08/2006



HIV One Step Rapid Test & Glucose Monitoring System received Quality Product SNQ Certification from Taiwan Biotechnology & Medical Committee.
EZ Smart 606 Blood Glucose Monitoring System receives Ministry of Health issued Medical Device Certificate (No.002170)

06/2006



EZ Smart 168 Blood Glucose Monitoring System receives Ministry of Health issued Medical Device Certificate (No.002161)
EZ Smart 168 Blood Glucose Monitoring System receives FDA approval (510K# K052818)

04/2006

Joint research and development with National Taiwan University on novel diagnostic method for Tuberculosis.

03/2006






Disposal lancet receives Ministry of Health issued Medical Device Certificate (No.000144)
In compliance to new medical guidance, Hepatitis C (HCV) receives Ministry of Health newly issued Medical Device Certificate (No.002003); old Certificate (No.000118 void)
In compliance to new medical guidance, HIV receives Ministry of Health newly issued Medical Device Certificate (No.002013); old Certificate (No.000119 void)

01/2006


Sponsor and support Taiwan AIDS Foundation and Taiwan Homesexual Foundation on HIV screening event

12/2005




EZ Smart Glucometer receives Ministry of Health issued Medical Device Certificate (No.001954)
Obtained People's Republic of China patent on "Revisable Biosensor" (No.239238)
Obtained People's Republic of China patent on "Biosensor Test Strip Structure" (No.ZL200420116622.2)

11/2005



EZ Smart control solution receives Ministry of Health issued Medical Device Certificate (No.000771)
EZ Smart test strip receives Ministry of Health issued Medical Device Certificate (No.001929)

06/2005



GMP auditing approval on EZ Smart lactometer
HIV One Step Rapid Test requested by Kaohsiung City Government Tender
Received Taiwan Patent (M268579) on "Biosensor Test Strip"

03/2005



GMP auditing approval on HIV, HCV One Step Rapid Test, EZ Smart Test Strip and control solution
EZ Smart Glucose product winning Turkey tender

01/2005

Tyson Bioresearch, Inc. USA office incorporated

10/2004



Received Innovative Product Recommendation Certificate from Ministry of Economics
HIV One Step Rapid Test receives People's Republic of China SDA approval (No.CS20040001)

09/2003



Awarded (1) Outstanding Company, (2) Outstanding Leadership, and (3) Outstanding Product award by Taiwan Management Association.
Selected by Ministry of Health in supporting Iraq Medical Initiative Program

07/2003



Received grant from Ministry of Economics on development of SARS One Step Rapid Test in amount of $300,000
Received validation approval by WHO appointed laboratory on HIV One Step Rapid Test

05/2003


Relocated Headquarters and manufacturing facility to HsinChu Science Based Industrial Park, ChuNan, Taiwan

04/2003


Obtained Certificate of Free Sales (domestic & international) from Ministry of Health on EZ Smart Glucose product

10/2002


Obtained CE Certification (TU01073-161)

09/2002


Obtained Manufacturing License from Ministry of Health on HIV One Step Rapid Test (No.000119)

08/2002


Obtained Manufacturing License from Ministry of Health on HIV One Step Rapid Test (No.000118)

01/2002


Received grant on development of Tuberculosis One Step Rapid Test in amount of $300,000

12/2001




Received Ministry of Health issued HIV One Step Rapid Test Exportation License (No.000112)
Received Ministry of Health issued HIV One Step Rapid Test Exportation License (No.000114)

08/2001


Obtained Company and Product trademark and Copyright

05/2001


Receive cGMP approval

02/2001


HIV One Step Rapid Test receives Brazil independent laboratory validation

12/2000


Received ISO 9001, EN 46001, and ISO 13485 certification and approval
Raised capital to $ 9.0 millions

10/2000



Completes HIV One Step Rapid Test technology transfer
Received validation approval by WHO appointed laboratory on HIV One Step Rapid Test

05/2000


Initiate pre-clinical study on glucose test strip
Raised capital to $ 6.5 millions

03/2000



Headquarters relocated to HsinChu Science Based Industrial Park, HsinChu, Taiwan
Raised capital to $ 4.5 millions

11/1999


Tyson Bioresearch, Inc. incorporated in Taipei,
Taiwan with capital of $ 2.5 millions


 

 
  Missions & Values

Our Mission
TysonBio is committed to developing, acquiring, and commercializing innovative diagnostic and management tools for both diabetes and infectious diseases. In our pursuit of making diabetes and infectious diseases more manageable, the Company is developing a diversified portfolio of diagnostic products focused on identifying new and more effective tools for disease diagnosis and management.

Corporate Values
Our priority and sense of purpose is our customer — the PATIENT. We are reminded daily that there is not a life or a moment to lose. TysonBio's patient focus shapes our culture, organization, and values.
Company success is dependent on our EMPLOYEES' creativity and dedication. Without this talent, commitment, and focus, we would not reach the ambitious goals we set for ourselves.
Our employees are dedicated to TEAMWORK. We have a true sense of ownership for our work and how it is tied directly to products that may significantly improve the outcome of patients' lives.
We feel a responsibility to give back to our COMMUNITY. We contribute to numerous local organizations and support employee initiatives beyond the workplace. Each year our TBer Award acknowledges employees who contribute to the community and exemplify the values of TysonBio.
The "patient first" focus gives us a greater understanding of our market — it is the key to serving our customers well and creating true SHAREHOLDER value. If we pay attention to, and are successful in achieving these values, our shareholders will benefit.
We are committed to personal, corporate, and scientific integrity. We produce QUALITY results as a consequence of high expectations.

 
  Offices & Facilities

Using a multidisciplinary approach to product development, TysonBio facilitates new product introduction through cross-enterprise collaboration and concurrent efforts. Within this process, guidelines can be tailored to specific program requirements.


With many years of engineering and biochemical research experience & process development, more than 40 engineers and researchers working concurrently on development and commercialization of electromedical and biochemical diagnostic devices, TysonBio provides the extensive capabilities to further improve the performance, throughput, yield, and drive to the most competitive manufacturing solutions:

Internal Vertical Supply Chain Enabling Competitive Cost
TysonBio manufactures and supplies the comprehensive BOM materials from the internal and local supply chains, and share with customers the significant advantages of material cost down.
Scalable and High Volume Capability & Capacity
With abundant skillful labor force and strong engineering and research team, TysonBio has proven the production scalability and established reputation for fast and smooth production ramp-up.
Successful Tracking Records on Biosensor Manufacturing
TysonBio has been serving electromedical and biosensor product contract manufacturing for leading industrial companies for years, which are great success for our customers and TysonBio.
Flexible Cooperation Model
Joint Production Line
Co-Invested by Customer and TysonBio
Exclusive Manufacturing Projects and Dedicated Production Lines

From the conception of a product idea to the regulatory approved product delivery, TysonBio’s vertically and horizontal integrated electro and biomedical manufacturing facility fulfills both the development and manufacturing needs of our partner.

 
 

HOME | ABOUT US | MANUFACTURE & OEM | PRODUCTS | Q&A | CONTACT US
  Copyright c 2007 Tyson Bioresearch, Inc., Hsin-Chu Science Based Park,
Taiwan. All rights reserved.